Search

everythinglearnresearchcommunity

for

Search:↓

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Permanent hair dye use may increase bladder cancer risk, especially in female smokers with certain genetic traits.

Biomedical innovations could extend human lifespan, but may impact pension systems.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Improving symptoms of male urinary problems may lower the risk of death.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.

Covid-19 worsens existing health issues and long-term effects are predictable.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

Anabolic-androgenic steroid abuse can cause heart damage and sudden death.

A severe virus outbreak in yaks on the Qinghai-Tibet Plateau caused high death rates and requires targeted control measures.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Understanding the Y chromosome is key to male health, aging, and developing diagnostic tools.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Patients at dermatology specialist hospitals had lower death and readmission rates but higher treatment costs.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Asian immigrant mothers in Leicestershire need better obstetric care to reduce higher perinatal mortality risks.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.